Article Information

• PDF (369 kb)
• Full Text with Thumbnail Figures
• Full Text with Large Figures
• Cited by in Scopus (169)
• Request permission

PubMed

• Articles by Tommy Pattij
• Articles by Louk J.M.J. Vanderschuren

Related Articles

• Impulsivity, Compulsivity, and Top-Down Cognitive Control

  Impulsivity, Compulsivity, and Top-Down Cognitive Control Neuron, Volume 69, Issue 4, 24 February 2011, Pages 680-694 Jeffrey W. Dalley, Barry J. Everitt and Trevor W. Robbins Summary Impulsivity is the tendency to act prematurely without foresight. Behavioral and neurobiological analysis of this construct, with evidence from both animal and human studies, defines several dissociable forms depending on distinct cortico-striatal substrates. One form of impulsivity depends on the temporal discounting of reward, another on motor or response disinhibition. Impulsivity is commonly associated with addiction to drugs from different pharmacological classes, but its causal role in human addiction is unclear. We characterize in neurobehavioral and neurochemical terms a rodent model of impulsivity based on premature responding in an attentional task. Evidence is surveyed that high impulsivity on this task precedes the escalation subsequently of cocaine self-administration behavior, and also a tendency toward compulsive cocaine-seeking and to relapse. These results indicate that the vulnerability to stimulant addiction may depend on an impulsivity endophenotype. Implications of these findings for the etiology, development, and treatment of drug addiction are considered. Summary | Full Text | PDF (878 kb)

• Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry

  Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry Trends in Cognitive Sciences, Volume 16, Issue 1, 1 January 2012, Pages 81-91 Trevor W. Robbins, Claire M. Gillan, Dana G. Smith, Sanne de Wit and Karen D. Ersche Abstract A key criticism of the main diagnostic tool in psychiatry, the Diagnostic and Statistical Manual of Mental Health Disorders (DSM-IV), is that it lacks a biological footing. In this article, we argue for a biological approach to psychiatry based on ‘neurocognitive endophenotypes’, whereby changes in behavioural or cognitive processes are associated with discrete deficits in defined neural systems. We focus on the constructs of impulsivity and compulsivity as key examples of the approach and discuss their possible cross-diagnostic significance, applying them to co-morbidities and commonalities across a range of disorders (attention-deficit/hyperactivity disorder, substance dependence, obsessive-compulsive disorder and eating disorders). We argue that this approach has important implications for the future classification of psychiatric disorders, genetics and therapeutics. Abstract | Full Text | PDF (573 kb)

• Decision making, impulsivity and time perception

  Decision making, impulsivity and time perception Trends in Cognitive Sciences, Volume 12, Issue 1, 1 January 2008, Pages 7-12 Marc Wittmann and Martin P. Paulus Abstract Time is an important dimension when individuals make decisions. Specifically, the time until a beneficial outcome can be received is viewed as a cost and is weighed against the benefits of the outcome. We propose that impulsive individuals experience time differently, that is with a higher cost. Impulsive subjects, therefore, overestimate the duration of time intervals and, as a consequence, discount the value of delayed rewards more strongly than do self-controlled individuals. The literature on time perception and impulsivity, however, is not clear cut and needs a better theoretical foundation. Here, we develop the theoretical background on concepts of time perception, which could lead to an empirically based notion of the association between an altered sense of time and impulsivity. Abstract | Full Text | PDF (391 kb)

• …more

Get Bookmark

• Add Bookmark
  • Delicious
  • Digg
  • Reddit
  • Facebook
  • StumbleUpon

Abstract

Impulsivity is a heterogenous phenomenon encompassing several behavioural phenomena that can be dissociated neuroanatomically as well as pharmacologically. Impulsivity is pathological in several psychiatric disorders including attention-deficit/hyperactivity disorder (ADHD), drug addiction and personality disorders. Pharmacological agents alleviating impulsivity therefore might substantially aid the treatment of these disorders. The availability of preclinical models that measure various forms of impulsivity has greatly increased our understanding of its neuropharmacological substrates. Historically, deficits in central serotonin neurotransmission are thought to underlie impulsivity. Accumulating evidence also points towards an important role of brain dopamine and noradrenaline systems in impulsive behaviour, consistent with the therapeutic efficacy of amphetamine, methylphenidate and atomoxetine in ADHD. However, recent findings also implicate glutamate and cannabinoid neurotransmission in impulsivity. In this review, we will discuss some of the recent developments in the neuropharmacological manipulation of impulsive behaviour.